BOSTON — The time for universal congenital cytomegalovirus (cCMV) screening may well be here, researchers said. In a study of nearly 24,000 newborns across six
In warning letters this week to 200,000 patients and 40,000 providers, University of North Carolina (UNC) Health accused insurance giant UnitedHealthcare of “not negotiating with
Regular use of chemical hair relaxers by Black women increased their risk of uterine cancer by 50%. (Boston University, Environmental Research) Adding the immune activator
PHILADELPHIA — Current anticoagulant or antiplatelet use is not necessarily a contraindication for administering tissue plasminogen activator (tPA) to a stroke patient in the emergency
BOSTON — A number of U.S. individuals who traveled to Matamoros, Mexico, for surgical procedures requiring anesthesia returned home with a fungal pathogen that caused
HONOLULU — Exposure to colder temperatures, especially those below 20°F, was associated with an increased risk for chronic obstructive pulmonary disease (COPD) exacerbations leading to
HONOLULU — In hindsight, researchers saw more limitations to extracorporeal membrane oxygenation (ECMO) and proning, therapies initially touted as helpful for COVID patients in intensive
In this video, Ryan Hassan, MD, MPH, a pediatrician at Oregon Pediatrics in Happy Valley and medical director of Boost Oregon in Portland, describes some
The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody. Welcome to MedPod Today, the podcast series where MedPage Today reporters share
BOSTON — Fostamatinib (Tavalisse) added to standard care reduced the number of days on supplemental oxygen and improved clinical status in hospitalized patients with COVID-19,